Thymosin Alpha-1 and LL-37 (Cap-18) Peptide Stack
LL-37 Thymosin Alpha-1 Peptide Stack is in Individual Vials (5mg LL-37 and 10mg Thymosin Alpha-1) laboratory research material supplied exclusively for controlled scientific and analytical research purposes.
99.5% purityBatch COA includedStore 2–8°C
$118.39
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
455 in stock
Researchers who bought Thymosin Alpha-1 and LL-37 (Cap-18) Peptide Stack also bought
Thymosin Alpha-1 and LL-37 (Cap-18) Peptide Stack
LL-37 Thymosin Alpha-1 Peptide Stack consists of two separate laboratory research materials: LL-37 (Cap-18), a 37-amino-acid human cathelicidin peptide, and Thymosin Alpha-1 (Tα1), a synthetic 28-amino-acid peptide. LL-37 is investigated in antimicrobial peptide biology, while Thymosin Alpha-1 is investigated in thymic peptide and immunological research. Direct SARMs Norway supplies each peptide separately in a sterile glass vial containing lyophilized powder. Where available, researchers are advised to review the Certificate of Analysis (COA) and HPLC purity documentation before using these research materials.
Benefits of the vial format
1
Accurate dosage. Peptides supplied in vials allow precise, consistent dosing for error-free research outcomes.
2
Convenience. Vials are small and easy to store and transport, helping maintain purity and efficacy.
3
Sterile packaging. Glass vials are sterile, reducing contamination risk and protecting sample integrity.
4
Maintains shelf life. Sealed vials prolong the usable life of the peptide and maintain its effectiveness.
5
Simple dispensing. A user-friendly format makes it simple to draw the intended research volume.
Visit LL-37 Research Hub ▸
Visit Thymosin Alpha-1 Research Hub. ▸
THYMOSIN ALPHA-1 AND LL-37 (CAP-18) is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy Thymosin Alpha-1 and LL-37 (Cap-18) Peptide Stack Norway from Direct SARMS.
Additional information
| Size | 5 mg |
| Purity | 98.0% |
| Molecular Formula | C205H340N60O53 |
| Molecular Weight | |
| Sequence | H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH |
| Physical Form | White or almost white lyophilized powder |
| Size | 10 mg |
| Purity | 99.5% |
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | |
| Sequence | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Physical Form | White or almost white lyophilized powder or loose mass |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the sealed lyophilised vial as stated on the product label. Once reconstituted, refrigerate and keep away from light. Do not refreeze a reconstituted solution.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this THYMOSIN ALPHA-1 AND LL-37 (CAP-18) compound?
The combination in the form of the Thymosin Alpha-1 and LL-37 (CAP-18) peptide is a product designed for research purposes and consists of two separate peptide compounds, Thymosin Alpha-1 and LL-37 (CAP-18), which are intended for use in laboratory studies. Both of the peptides have already been studied on their own in scientific research involving peptide structure, molecular interactions, and biological pathways. The product is provided exclusively for research use and is not meant for human consumption.
A peptide stack format enables researchers to study two different peptide compounds within the same experimental setup. The combination of Thymosin Alpha-1 and LL-37 (CAP-18) has no approved application, unvalidated result, or proven suitability for use in humans. Research with these materials should be carried out according to the appropriate laboratory procedures and relevant scientific standards.
Thymosin Alpha-1 and LL-37 (CAP-18) are different peptide compounds which have different molecular structures and distinct research histories. Even though both have been investigated in the area of peptide biology, they are separate substances and therefore should be assessed individually when looking at the scientific literature.
Scientific papers have looked at Thymosin Alpha-1 and LL-37 (CAP-18) separately in experimental studies concerning peptide mechanisms, molecular pathways, and biological interactions. The information given here is offered solely as scientific reference and must not be regarded as proof of therapeutic effects, medical uses, or as indicating that it is suitable for human use.
No, this product is only supplied for use in laboratory research and is not meant for human consumption, for clinical use, for medical applications, for therapeutic use, or as a dietary supplement. It does not include any dosing instructions, administration advice, or recommendations regarding its use in humans.
Certificate of Analysis
| Identity | THYMOSIN ALPHA-1 AND LL-37 (CAP-18) | CONFORMS |
| Purity (HPLC) | 99.5% | CONFORMS |
| Appearance | White or almost white lyophilized powder or loose mass | CONFORMS |
